
Loading, please wait...

Loading, please wait...

The human stomach serves as more than just a digestive vessel; it is a sophisticated sensory organ. Central to this sensing capability is gastric nuclear receptor signaling, which interprets signals from ingested food and toxins. Nuclear receptors (NRs) are evolutionarily conserved proteins that act as transcription factors. These molecules regulate gene expression in response to environmental and hormonal stimuli. Therefore, understanding these pathways offers a bridge between external dietary factors and internal physiological balance.
Notably, the stomach hosts numerous NRs that dictate cell fate determination and normal development. These receptors respond to xenobiotics and pollutants, which is crucial since the stomach is a primary entry point for contaminants. Furthermore, signals from other organs engage gastric NRs to modulate physiology. Consequently, these interactions determine the activity of stem cells and acid-secreting parietal cells. Thus, NR signaling acts as a critical regulator of gastric architecture and functional integrity.
Moreover, disruptions in these signaling pathways contribute significantly to pathological states. Research demonstrates that NRs influence the development of precancerous lesions and gastric cancer. In addition, these receptors provide novel opportunities for pharmacological intervention. Identifying specific agonists and antagonists can help treat chronic conditions like gastritis and intestinal metaplasia. Therefore, targeting nuclear receptors represents a promising frontier in gastrointestinal oncology and metabolic medicine.
Nuclear receptors act as transcription factors that regulate gene expression. They manage cell differentiation, maintain homeostasis, and sense dietary toxins to protect the gastric lining.
The stomach is one of the first organs to encounter dietary compounds and environmental pollutants. These substances trigger specific nuclear receptors, which then adjust the activity of gastric stem cells and acid secretion.
Yes, researchers are investigating NRs as therapeutic targets. By using specific agonists or antagonists, clinicians may be able to modulate the pathological pathways involved in gastritis and gastric malignancy.
Disclaimer: This content is for informational and educational purposes only. It does not constitute medical advice or a substitute for professional healthcare. Always consult with a qualified healthcare provider regarding medical conditions or treatments. Refer to the latest local and national guidelines for clinical practice.
References
Divenko M et al. Stomach at the Crossroads: Nuclear Receptor Signaling at the Interface Between What We Are and What We Eat. Physiol Rev. 2026 Feb 24. doi: 10.1152/physrev.00033.2025. PMID: 41732976.
Tanaka T, De Luca LM. Therapeutic potential of nuclear receptors in the digestive tract. Journal of Gastroenterology. 2017;52(4):423-435. doi: 10.1007/s00535-017-1311-2.
Wang Z, et al. Nuclear receptor retinoid-related orphan receptor alpha promotes apoptosis but is reduced in human gastric cancer. Oncotarget. 2017;8(10):16311-16321. doi: 10.18632/oncotarget.13958.

Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.


A detailed look at the role of nuclear receptors in gastric homeostasis, environmental response, and as therapeutic targets for gastritis and gastric cancer...
6 months ago

A nationwide study reveals stable pathogen specification rates in infectious diarrhea hospitalizations from 2016 to 2023, accompanied by a marked decline in Clostridioides difficile cases, emphasizing the need for targeted diagnostic stewardship and thoughtful multiplex testing in hospital medicine.
4 days back

A real-world cohort study evaluates anti-Müllerian hormone recovery and fertility outcomes in high-risk GTN patients treated with EMA/CO versus FAEV chemotherapy, demonstrating robust ovarian reserve recovery by six months post-treatment.
4 days back

A real-world Japanese claims database analysis reveals that the 2021 heart failure guideline update drove significant improvements in guideline-directed medical therapy (GDMT). The study highlighted substantial increases in the prescription of sacubitril/valsartan and dapagliflozin among heart failure patients.
4 days back

A multicenter prospective cohort study reveals that 54.1% of patients achieve clinically meaningful neuropathic pain relief after surgery for degenerative cervical myelopathy, driving substantial gains in motor function, mental health, and quality of life.
4 days back

The ferroptosis-immunity axis represents a critical driver of diabetic kidney disease progression. This review explores iron-dependent lipid peroxidation, innate immune cross-talk, emerging candidate biomarkers, and promising targeted therapies to delay renal decline alongside standard glycemic control.
4 days back